Abstract
Objective
Among variants of the butyrylcholinesterase gene (BChE), the K-variant causing Ala539Thr substitution is the most common one associated with about one-third reduction in the enzyme activity. This study aimed to detect the frequency of the K-variant allele in a Turkish population sample and also to evaluate how the plasma BChE activity was influenced by this variant.
Methods
Patients administered for elective surgery (n=77) were examined for the presence of the K allele. The enzyme activity was determined in plasma.
Results
The K-variant of BChE is a common allele with a frequency of 0.266 (CI95% 0.196–0.336) in our sample from a Turkish population. Mean enzyme activity in subjects homozygous for the K-variant was about 40% lower than other subjects.
Conclusion
The frequency of the BChE K-variant was significantly higher in a Turkish population than those reported for other populations and it is associated with a diminished enzyme activity.
Similar content being viewed by others
References
Viby-Mogensen J (1980) Correlation of succinylcholine duration of action with plasma cholinesterase activity in subjects with the genotypically normal enzyme. Anesthesiology 53:517–520
Ostergaard D, Jensen FS, Jensen E, Skovgaard LT, Viby-Mogensen J (1992) Influence of plasma cholinesterase activity on recovery from mivacurium-induced neuromuscular blockade in phenotypically normal patients. Acta Anaesthesiol Scand 36:702–706
Jensen FS, Viby-Mogensen J (1995) Plasma cholinesterase and abnormal reaction to succinylcholine: twenty years’ experience with the Danish Cholinesterase Research Unit. Acta Anaesthesiol Scand 39:150–156
Lockridge O (1990) Genetic variants of human serum cholinesterase influence metabolism of the muscle relaxant succinylcholine. Pharmacol Ther 47:35–60
Sudo K, Maekawa M, Kanno T, Akizuki S, Magara T (1996) Three different point mutations in the butyrylcholinesterase gene of three Japanese subjects with a silent phenotype: possible Japanese type alleles. Clin Biochem 29:165–169
Primo-Parmo SL, Bartels CF, Wiersema B, van der Spek AF, Innis JW, La Du BN (1996) Characterization of 12 silent alleles of the human butyrylcholinesterase (BCHE) gene. Am J Hum Genet 58:52–64
Bartels CF, James K, La Du BN (1992) DNA mutations associated with the human butyrylcholinesterase J-variant. Am J Hum Genet 50:1104–1114
Rubinstein HM, Dietz AA, Lubrano T (1978) E1k, another quantitative variant at cholinesterase locus 1. J Med Genet 15:27–29
Bartels CF, Jensen FS, Lockridge O, van der Spek AF, Rubinstein HM, Lubrano T, La Du BN (1992) DNA mutation associated with the human butyrylcholinesterase K-variant and its linkage to the atypical variant mutation and other polymorphic sites. Am J Hum Genet 50:1086–1103
Whittaker M, Britten JJ (1985) Plasma cholinesterase variants: family studies of the E1k gene. Hum Hered 35:364–368
Evans RT, Wardell J (1984) On the identification and frequency of the J and K cholinesterase phenotypes in a Caucasian population. J Med Genet 21:99–102
Whittaker M (1986) Cholinesterase. Karger, Basel
Jensen FS, Nielsen LR, Schwartz M (1996) Detection of the plasma cholinesterase K-variant by PCR using an amplification-created restriction site. Hum Hered 46:26–31
Alcantara VM, Chautard-Freire-Maia EA, Picheth G, Vieria MM (1990) Frequency of the CHE1*K allele of serum cholinesterase in a sample from southern Brazil. Hum Hered 40:386–390
Yamamoto Y, Yasuda M, Mori E, Maeda K (1999) Failure to confirm a synergistic effect between the K-variant of the butyrylcholinesterase gene and the epsilon4 allele of the apolipoprotein gene in Japanese patients with Alzheimer’s disease. J Neurol Neurosurg Psychiatry 67:94–96
Jensen FS, Skovgaard LT, Viby-Mogensen J (1995) Identification of human plasma cholinesterase variants in 6,688 individuals using biochemical analysis. Acta Anaesthesiol Scand 39:157–162
Viby-Mogensen J (1981) Succinylcholine neuromuscular blockade in subjects homozygous for atypical plasma cholinesterase. Anesthesiology 55:429–434
Cara DM, Armory P, Mahajan RP (2000) Prolonged duration of neuromuscular block with rapacuronium in the presence of sevoflurane. Anesth Analg 91:1392–1393
Koseoglu V, Chiang J, Chan KW (1999) Acquired pseudocholinesterase deficiency after high-dose cyclophosphamide. Bone Marrow Transplant 24:1367–1368
Davies JM, Carmichael D, Dymond C (1983) Plasma cholinesterase and trophoblastic disease. Gestational trophoblastic disease and reduced activity of plasma cholinesterase. Anaesthesia 38:1071–1074
Kao YJ, Turner DR (1989) Prolongation of succinylcholine block by metoclopramide. Anesthesiology 70:905–908
Acknowledgements
This study was supported by the Turkish Scientific and Technological Research Council TUBITAK (SBAG-COST B15–2356) and Turkish Academy of Sciences.The authors gratefully acknowledge Prof. Semsettin Ustacelebi for generously allocating laboratory facilities and thank Cetin Akin for his assistance in genotyping. All experiments were conducted in accordance with the current laws of Turkey.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Babaoglu, M.O., Ocal, T., Bayar, B. et al. Frequency and enzyme activity of the butyrylcholinesterase K-variant in a Turkish population. Eur J Clin Pharmacol 59, 875–877 (2004). https://doi.org/10.1007/s00228-003-0716-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00228-003-0716-x